drugset / Trial / NCT04388215
Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet
RandomizedParallel-groupQuadruple-blindTreatment
Summary
to evaluate the efficacy and safety of CKD-828, D326, and D337 combination therapy in Hypertensive patients with Dyslipidemia
Timeline
- Start
- 2019-10-23
- Primary completion
- 2021-04
- Completion
- 2021-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-828 | Unknown | — | Oral |
| Comparator | D013 | Unknown | 80 mg | Oral |
| Subject | D326 | Unknown | 20 mg | Oral |
| Subject | D337 | Unknown | 10 mg | Oral |